Particle.news
Clinical Trials Drug Trials Patient Outcomes Study Findings Drug Development Drug Efficacy Epidemiology Drug Studies Data Analysis Medical Studies Observational Studies Case Studies Study Design Systematic Reviews Phase 3 Trials Animal Models Genomic Medicine Patient Safety FDA Approvals Drug Safety Longitudinal Studies Pharmacology Meta-Analysis AI in Medicine Therapeutics Patient Studies Vaccine Development Vaccine Efficacy Effectiveness Studies Drug Approval Patient Trials Breakthrough Therapy Designation Hypertension Experimental Treatments Phase III Trials Studies Medication Efficacy Health Outcomes Collaboration Cancer Genomics Anesthesiology Patient Monitoring Medical Trials Neurology Blood Thinners Regulatory Affairs Genetic Disorders Diagnostic Accuracy Animal Studies Radiological Society of North America Trials Cancer Research Systematic Analysis Data Management Laboratory Testing Nasal Liquid Biopsies Investigatory Reviews Natural Experiments Drug Repurposing Medical Breakthroughs Adverse Effects HIV Treatment Trial Methodology Radiology Studies Rating Scales Obesity Treatments Trial Design Cohort Studies Eli Lilly Phase Trials Efficacy Studies Retrospective Studies Disease Diagnosis Biomedical Research Randomized Controlled Trials Placebo Studies Vaccine Trials Vaccine Studies Phase 1 Trials Diagnostic Tests Diagnostic Methods Pharmaceutical Studies Botanical Products TCR-T Therapies Randomized Trials Drug Discovery Epilepsy Treatment Chronic Illnesses Stroke Prevention Treatment Strategies Algorithm Development Statistical Analysis Translational Medicine Neurocognitive Assessments Postmarketing Studies Genomics Treatment Efficacy Blood Pressure Measurement
St. Vincent's Hospital in Sydney has pioneered the use of normothermic machine perfusion, preserving donor hearts for up to ten hours and expanding transplant logistics across Australia and potentially to the Pacific and Asia.
